Sun Pharma Corporate Overview

Highly Diversified Revenue Base India Branded Formulations 31% Emerging Markets © Sun Pharmaceutical Industries Limited. All Rights Reserved. 18% FY21 Sales Rs. 331 billion Western Europe & Other Markets # 15% API & Others 6% US Formulations 30% SUN PHARMA # Includes Western Europe, Canada, Japan, Australia, New Zealand and other markets. 10

View entire presentation